The Food and Drug Administration (FDA) has classified an autosomal recessive carrier screening gene mutation detection system into class II (special controls). The special controls that apply to this device are identified in this order and will be part of the codified language for the autosomal recessive carrier screening gene mutation detection system classification. The Agency has classified the device into class II (special controls) in order to provide a reasonable assurance of safety and effectiveness of the device.
Document
Medical Devices; Immunology and Microbiology Devices; Classification of Autosomal Recessive Carrier Screening Gene Mutation Detection System
The Food and Drug Administration (FDA) has classified an autosomal recessive carrier screening gene mutation detection system into class II (special controls). The special contr...
Legal Citation
Federal Register Citation
Use this for formal legal and research references to the published document.
80 FR 65626
Web Citation
Suggested Web Citation
Use this when citing the archival web version of the document.
“Medical Devices; Immunology and Microbiology Devices; Classification of Autosomal Recessive Carrier Screening Gene Mutation Detection System,” thefederalregister.org (October 27, 2015), https://thefederalregister.org/documents/2015-27197/medical-devices-immunology-and-microbiology-devices-classification-of-autosomal-recessive-carrier-screening-gene-mutatio.